Curcumin analogs
US9738623B2 · kind B2 · utility
0Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2013 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Aug 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/022
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are curcumin analogues that are able to interact with amyloid β (Aβ) and to attenuate the copper-induced crosslinking of Aβ. Also provided herein are methods of using the compounds in the treatment of Alzheimer's Disease or a related disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.